Filing Details
- Accession Number:
- 0000914190-12-000480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-15 17:25:47
- Reporting Period:
- 2012-08-13
- Filing Date:
- 2012-08-15
- Accepted Time:
- 2012-08-15 17:25:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180145 | Cardiovascular Systems Inc | CSII | Surgical & Medical Instruments & Apparatus (3841) | 411698056 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304318 | David Martin | 651 Campus Drive St. Paul MN 55112 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-13 | 27,293 | $0.00 | 312,673 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2012-08-13 | 27,293 | $0.00 | 339,966 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2012-08-13 | 54,584 | $0.00 | 394,550 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2012-08-13 | 8,204 | $8.85 | 386,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-08-15 | 3,324 | $8.92 | 383,022 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $8.83 | 2016-07-16 | 71,170 | 71,170 | Direct | |
| Common Stock | Stock Option (right to buy) | $8.83 | 2016-08-14 | 38,820 | 38,820 | Direct | |
| Common Stock | Stock Option (right to buy) | $8.83 | 2017-02-14 | 349,380 | 349,380 | Direct | |
| Common Stock | Stock Option (right to buy) | $7.90 | 2017-06-11 | 90,580 | 90,580 | Direct | |
| Common Stock | Stock Option (right to buy) | $12.15 | 2017-12-11 | 242,625 | 242,625 | Direct | |
| Common Stock | Stock Option (right to buy) | $8.75 | 2019-03-01 | 32,350 | 32,350 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2016-07-16 | 71,170 | 71,170 | Direct |
| 2016-08-14 | 38,820 | 38,820 | Direct |
| 2017-02-14 | 349,380 | 349,380 | Direct |
| 2017-06-11 | 90,580 | 90,580 | Direct |
| 2017-12-11 | 242,625 | 242,625 | Direct |
| 2019-03-01 | 32,350 | 32,350 | Direct |
Footnotes
- Subject to performance-based forfeiture based on total shareholder return for fiscal 2013 versus the Company's peer group.
- Subject to performance-based forfeiture based on annual revenue growth for fiscal 2013 versus the Company's peer group.
- Restrictions lapse over a three year period.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.62 to $9.16 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.83 to $9.00 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Fully exercisable.
Billionaire Hedge Funds
